Not applicableStudy completedNCT02162732What this trial is testingMolecular-Guided Therapy for Childhood CancerWho this might be right forNeuroblastomaMedulloblastomaGlioma+16 more Giselle Sholler 186
Early research (Phase 1)Not Yet RecruitingNCT05698238What this trial is testingClinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid TumoursWho this might be right forClear Cell Renal Cell Carcinoma MetastaticTNBC - Triple-Negative Breast CancerHead and Neck Cancer+2 more Mabpro, a.s. 50
Testing effectiveness (Phase 2)UnknownNCT06129955What this trial is testingPucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Sun Yat-sen University 47
Testing effectiveness (Phase 2)Looking for participantsNCT04977453What this trial is testingGI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid TumorCervical Cancer+3 more GI Innovation, Inc. 317
Testing effectiveness (Phase 2)Active Not RecruitingNCT05620134What this trial is testingStudy of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerWho this might be right forCancerTumor, SolidAdvanced Solid Tumor+19 more Salubris Biotherapeutics Inc 263
Testing effectiveness (Phase 2)Study completedNCT01108445What this trial is testingPhase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell CarcinomaWho this might be right forAdvanced Non-clear Cell Renal Cell Carcinoma Duke University 131
Early research (Phase 1)Active Not RecruitingNCT05544929What this trial is testingSafety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced CancersWho this might be right forCarcinoma, Non-Small-Cell LungCutaneous MelanomaCarcinoma, Renal Cell+9 more Novartis Pharmaceuticals 126
Testing effectiveness (Phase 2)Active Not RecruitingNCT05831891What this trial is testingFruquintinib Plus Serplulimab as First-Line Therapy for Metastatic Non-Clear Cell Renal Cell CarcinomaWho this might be right forNon-clear Cell Renal Cell Carcinoma RenJi Hospital 40
Large-scale testing (Phase 3)Study completedNCT03849118What this trial is testing89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON StudyWho this might be right forClear Cell Renal Cell Carcinoma Telix Pharmaceuticals (Innovations) Pty Limited 300
Early research (Phase 1)Looking for participantsNCT07517198What this trial is testingDose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid TumorsWho this might be right forSolid TumorSmall Cell Lung Cancer (SCLC)High Grade Neuroendocrine Cancer+9 more Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06380816What this trial is testingA Phase I/II Trial of UCB4594 in Participants With Advanced CancerWho this might be right forAdvanced Solid TumoursSquamous Cell Carcinoma of Head and NeckCarcinoma, Non-Small-Cell Lung+8 more Cancer Research UK 167
Early research (Phase 1)Looking for participantsNCT06242470What this trial is testingMGC026 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorAdvanced CancerMetastatic Cancer+19 more MacroGenics 250
Early research (Phase 1)Looking for participantsNCT04777994What this trial is testingStudy With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic TumorsWho this might be right forAdvanced Solid Tumor Cancer Calico Life Sciences LLC 248
Testing effectiveness (Phase 2)UnknownNCT04958473What this trial is testingSintilimab in Combination With Axitinib in Advanced Renal Cell CancerWho this might be right forRenal Cell CarcinomaClear Cell Renal Cell Carcinoma Tianjin Medical University Second Hospital 40
Not applicableStudy completedNCT00253383What this trial is testingEarly Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer PatientsWho this might be right forCancer Dartmouth-Hitchcock Medical Center 329
Early research (Phase 1)Looking for participantsNCT06026410What this trial is testingKO-2806 Monotherapy and Combination Therapies in Advanced Solid TumorsWho this might be right forSolid Tumors With HRAS AlterationsNon Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+4 more Kura Oncology, Inc. 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT05286294What this trial is testingMicrobiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical RespondersWho this might be right forMelanoma Stage IVHead and Neck Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma+3 more Oslo University Hospital 20
Early research (Phase 1)Study completedNCT01625351What this trial is testingCD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and LymphomasWho this might be right forEwing SarcomaGastrointestinal TumorGerm Cell Tumor+10 more St. Jude Children's Research Hospital 23
Testing effectiveness (Phase 2)Looking for participantsNCT05267626What this trial is testingStudy of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic CancerWho this might be right forAdvanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more Aulos Bioscience, Inc. 159
Early research (Phase 1)Active Not RecruitingNCT05277051What this trial is testingFirst-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid TumorsWho this might be right forNeoplasms GlaxoSmithKline 152